ADC Therapeutics SA
NYSE:ADCT
ADC Therapeutics SA
Other Long-Term Assets
ADC Therapeutics SA
Other Long-Term Assets Peer Comparison
Competitive Other Long-Term Assets Analysis
Latest Figures & CAGR of Competitors
Company | Other Long-Term Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
ADC Therapeutics SA
NYSE:ADCT
|
Other Long-Term Assets
$711k
|
CAGR 3-Years
21%
|
CAGR 5-Years
19%
|
CAGR 10-Years
N/A
|
|
AC Immune SA
NASDAQ:ACIU
|
Other Long-Term Assets
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
CRISPR Therapeutics AG
NASDAQ:CRSP
|
Other Long-Term Assets
$13.6m
|
CAGR 3-Years
-9%
|
CAGR 5-Years
29%
|
CAGR 10-Years
N/A
|
|
Basilea Pharmaceutica AG
SIX:BSLN
|
Other Long-Term Assets
CHf44k
|
CAGR 3-Years
-48%
|
CAGR 5-Years
-27%
|
CAGR 10-Years
-8%
|
|
Idorsia Ltd
SIX:IDIA
|
Other Long-Term Assets
CHf47.5m
|
CAGR 3-Years
74%
|
CAGR 5-Years
88%
|
CAGR 10-Years
N/A
|
|
Kuros Biosciences AG
SIX:KURN
|
Other Long-Term Assets
CHf651k
|
CAGR 3-Years
30%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is ADC Therapeutics SA's Other Long-Term Assets?
Other Long-Term Assets
711k
USD
Based on the financial report for Dec 31, 2023, ADC Therapeutics SA's Other Long-Term Assets amounts to 711k USD.
What is ADC Therapeutics SA's Other Long-Term Assets growth rate?
Other Long-Term Assets CAGR 5Y
19%
Over the last year, the Other Long-Term Assets growth was -97%. The average annual Other Long-Term Assets growth rates for ADC Therapeutics SA have been 21% over the past three years , 19% over the past five years .